Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1

Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1

US Patent 9987351 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aptamer-based CAR T-cell switch2025
Viral vector constructs for expression of genetic adjuvants activating the CD40 2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Lentiviral vectors for regulated expression of a chimeric antigen receptor molec2020
Lyophilized lentiviral vector particles, compositions and methods2020
Vectors for molecule delivery to CD11b expressing cells2018
Use of non-subtype B gag proteins for lentiviral packaging2017
Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin 2017
Recombinant adenylate cyclase toxin of bordetella induces T cell responses again2016
Vectors for molecule delivery to CD11b expressing cells2016
Lentiviral vectors containing an MHC class I promoter2015
Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interacti2011